Showing results (171-180 of 522) with videos related to

Sort By:
Pageof 53
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 5, 2026
Targeting MET in EGFR-mutated NSCLCStephanie P L Saw, Molly S C Li, Sehhoon Park, et al.
Nature Reviews. Disease Primers|August 21, 2025
Lung metastasesLodovica Zullo, Dimitris Filippiadis, Lizza E L Hendriks, et al.
European Radiology|June 15, 2016
Diagnostic yield of a biopsy performed immediately after lung radiofrequency ablationLambros Tselikas, Thierry de Baere, Frederic Deschamps, et al.
Cancer Management and Research|April 5, 2021
Meningeal "Lazarus Response" to Lorlatinib in a ROS1-Positive NSCLC Patient Progressing to EntrectinibFrancesco Facchinetti, Antonin Levy, Samy Ammari, et al.
European Journal of Cancer (Oxford, England : 1990)|August 18, 2024
Assessing actionability and incidental findings of germline variants in two precision oncology trialsMaria Baz Ibrahim, Yahia Adnani, Gérôme Jules Clément, et al.
JAMA Oncology|September 8, 2018
Hyperprogressive Disease in Patients With Advanced Non-Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With Single-Agent ChemotherapyRoberto Ferrara, Laura Mezquita, Matthieu Texier, et al.
JCO Precision Oncology|September 14, 2020
Clinical Relevance of an Amplicon-Based Liquid Biopsy for Detecting ALK and ROS1 Fusion and Resistance Mutations in Patients With Non-Small-Cell Lung CancerLaura Mezquita, Aurélie Swalduz, Cécile Jovelet, et al.
Lung Cancer (Amsterdam, Netherlands)|December 20, 2024
An international and multidisciplinary EORTC survey on resectability of stage III non-small cell lung cancerIlias Houda, Idris Bahce, Chris Dickhoff, et al.
Cancer Treatment and Research Communications|May 12, 2023
Antibody-drug conjugates, immune-checkpoint inhibitors, and their combination in advanced non-small cell lung cancerIdoko Salifu, Navneet Singh, Maria Berraondo, et al.
JTO Clinical and Research Reports|July 31, 2025
Parallel Phase II Clinical Trials of Selinexor in Patients With Advanced Thymoma and Thymic CarcinomaChul Kim, Vanya Aggarwal, Gedske Daugaard, et al.
Pageof 53